Trade Names: | |
Synonyms: | |
Status: | Approved (2015) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | C01EB17 |
UNII: | 3H48L0LPZQ |
InChI Key | ACRHBAYQBXXRTO-OAQYLSRUSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C27H36N2O5 |
Molecular Weight | 468.59 |
AlogP | 3.31 |
Hydrogen Bond Acceptor | 6.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 10.0 |
Polar Surface Area | 60.47 |
Molecular species | BASE |
Aromatic Rings | 2.0 |
Heavy Atoms | 34.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Voltage-gated ion channel
Cyclic nucleotide-regulated channel
|
4280 | - | - | - | 47 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Hypotension, Orthostatic | 3 | D007024 | ClinicalTrials |
Heart Failure | 3 | D006333 | ClinicalTrials |
Aging | 3 | D000375 | ClinicalTrials |
Angina, Stable | 3 | D060050 | ClinicalTrials |
Heart Failure | 3 | D006333 | ClinicalTrials |
Diabetic Nephropathies | 3 | D003928 | ClinicalTrials |
Mitral Valve Stenosis | 3 | D008946 | ClinicalTrials |
Atrial Fibrillation | 3 | D001281 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Shock, Septic | 3 | D012772 | ClinicalTrials |
Tachycardia | 3 | D013610 | ClinicalTrials |
Coronary Disease | 3 | D003327 | ClinicalTrials |
Non-ST Elevated Myocardial Infarction | 2 | D000072658 | ClinicalTrials |
Lymphoma | 2 | D008223 | ClinicalTrials |
Heart Failure, Diastolic | 2 | D054144 | ClinicalTrials |
Heart Failure, Systolic | 2 | D054143 | ClinicalTrials |
Multiple Organ Failure | 2 | D009102 | ClinicalTrials |
Hypotension | 2 | D007022 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 155974-00-8 |
ChEBI | 85966 |
ChEMBL | CHEMBL471737 |
DrugBank | DB09083 |
DrugCentral | 3312 |
EPA CompTox | DTXSID2048240 |
FDA SRS | 3H48L0LPZQ |
Guide to Pharmacology | 2357 |
PharmGKB | PA166123415 |
PubChem | 132999 |
SureChEMBL | SCHEMBL23472 |
ZINC | ZINC000003805768 |